- Home
- SIGI vs TFX Comparison
SIGI vs TFX Comparison
Compare SIGI & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGI
- TFX
- Stock Information
- Founded
- SIGI 1926
- TFX 1943
- Country
- SIGI United States
- TFX United States
- Employees
- SIGI N/A
- TFX N/A
- Industry
- SIGI Property-Casualty Insurers
- TFX Medical/Dental Instruments
- Sector
- SIGI Finance
- TFX Health Care
- Exchange
- SIGI Nasdaq
- TFX Nasdaq
- Market Cap
- SIGI 5.5B
- TFX 5.1B
- IPO Year
- SIGI N/A
- TFX N/A
- Fundamental
- Price
- SIGI $77.60
- TFX $115.99
- Analyst Decision
- SIGI Hold
- TFX Hold
- Analyst Count
- SIGI 7
- TFX 10
- Target Price
- SIGI $87.33
- TFX $160.13
- AVG Volume (30 Days)
- SIGI 781.0K
- TFX 590.5K
- Earning Date
- SIGI 07-23-2025
- TFX 07-31-2025
- Dividend Yield
- SIGI 1.94%
- TFX 1.15%
- EPS Growth
- SIGI 66.75
- TFX N/A
- EPS
- SIGI 6.11
- TFX 4.18
- Revenue
- SIGI $5,112,631,000.00
- TFX $3,041,342,000.00
- Revenue This Year
- SIGI $5.31
- TFX $3.50
- Revenue Next Year
- SIGI $6.91
- TFX $5.33
- P/E Ratio
- SIGI $12.79
- TFX $28.36
- Revenue Growth
- SIGI 12.30
- TFX 1.11
- 52 Week Low
- SIGI $71.75
- TFX $108.90
- 52 Week High
- SIGI $103.56
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- SIGI 39.56
- TFX 49.11
- Support Level
- SIGI $77.33
- TFX $111.91
- Resistance Level
- SIGI $79.07
- TFX $123.79
- Average True Range (ATR)
- SIGI 2.79
- TFX 3.27
- MACD
- SIGI -0.26
- TFX 0.36
- Stochastic Oscillator
- SIGI 29.43
- TFX 34.30
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.